Common use of Discussion of Unapproved Uses Clause in Contracts

Discussion of Unapproved Uses. Provider represents and warrants that if an unlabeled (unapproved) use of a commercial product, or an investigational use not yet approved for any purpose by the FDA, is discussed during the educational activity, Provider will require disclosure that the product is not labeled for the use under discussion or that the product is still investigational.